Objective: Aim of this study was to evaluate clinical variables related with relapse to alcohol abuse during 12 months follow-up after inpatient treatment in male alcohol dependents. Method: Participants were 156 consecutively admitted male alcohol dependents. Among these patients, 102 were available at the evaluation that took place one year after the inpatient treatment. Patients were investigated with the Symptom Check List (SCL-90) and Michigan Alcoholism Screening Test (MAST) at baseline and with the PENN Alcohol Craving Scale (PACS) one year later, at follow-up. Results: Among 102 alcohol dependent inpatients, 61.8% (n=63) were considered as relapsed to alcohol abuse. Sociodemographic variables did not differ between groups. Mean scores of MAST and global severity index of SCL-90 did not differ significantly between groups, whereas craving score was higher in the relapsed group. Also the relapsed group had less polyclinic control, less attendance to the Outpatient Treatment Program (OTP), less changes in social environment for self protection and less use of anti-craving medications during one year follow-up. Severity of craving and not attending OTP during follow-up period predicted relapse in alcohol dependents. Conclusions: Severity of craving and not attending OTP seems to be the main factors related with relapse. Together with using anti-craving medications, regular attendance to OTP may help patients to recognize and manage with alcohol craving.
Alcohol dependence, craving, relapse, therapy
Article Language: Turkish English Similar Articles
Paclitaxel-loaded magnetic nanocrystals for tumor neovascular-targeted theranostics: an amplifying synergistic therapy combining magnetic hyperthermia with chemotherapy.
Liu S, Shi D, Chen L, Yan Y, Wang X, Song Y, Pu S, Liang Y, Zhao Y, Zhang Y, Xie J
Nanoscale. 2021; 13(6): 3613-3626
A systematic literature review and meta-analysis of the clinical effects of aroma inhalation therapy on sleep problems.
Cheong MJ, Kim S, Kim JS, Lee H, Lyu YS, Lee YR, Jeon B, Kang HW
Medicine. 2021; 100(9): e24652
A Legal Right to Clozapine Therapy for Incarcerated Individuals With Treatment-Resistant Schizophrenia.
Zarzar TR, Williams JB, Pruette ME, Sheitman BB
Psychiatric services (Washington, D.C.). 2021; (): appips202000845
Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life.
Loochi SA, Demol S, Nagelberg N, Lebenthal Y, Phillip M, Yackobovitch-Gavan M
Journal of pediatric endocrinology & metabolism : JPEM. 2021; ():
Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - An in silico study.
Gowrishankar S, Muthumanickam S, Kamaladevi A, Karthika C, Jothi R, Boomi P, Maniazhagu D, Pandian SK
Food and chemical toxicology : an international journal published for the British Industrial Biolog. 2021; 148(): 111966
Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer.
Zhao H, Lei X, Niu J, Zhang N, Duan Z, Chavez-MacGregor M, Giordano SH
JCO oncology practice. 2021; (): OP2000248
A fusion transcription factor-driven cancer progresses to a fusion-independent relapse via constitutive activation of a downstream transcriptional target.
Boudjadi S, Pandey PR, Chatterjee B, Nguyen TH, Sun W, Barr FG
Cancer research. 2021; ():
Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature Review.
Cobo M, RodrÃguez-Abreu D, PÃ©rez Parente D, Ruiz Gracia P, GonzÃ¡lez JG
Oncology and therapy. 2021; ():